<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Sch of Geography, Earth &amp; Env Sciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1F257D5A-AA9A-4460-9953-37368441A1EA"><gtr:id>1F257D5A-AA9A-4460-9953-37368441A1EA</gtr:id><gtr:name>University of Calgary</gtr:name><gtr:address><gtr:line1>2500 University Drive</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5D4C648B-9A53-4E4B-9A90-AF69814C66B0"><gtr:id>5D4C648B-9A53-4E4B-9A90-AF69814C66B0</gtr:id><gtr:firstName>Bertus</gtr:firstName><gtr:surname>Eksteen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6524"><gtr:id>DD872DFF-7CF8-47FD-BEE8-55A5BA5A51EE</gtr:id><gtr:title>Aberrant expression of gut chemokines promotes the recruitment of mucosal lymphocytes to the liver in Primary Sclerosing</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6524</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>101570</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Harvard University</gtr:description><gtr:id>E67C25BB-5984-408B-A61D-19283D34F554</gtr:id><gtr:impact>17110582, 19233184</gtr:impact><gtr:outcomeId>41716ED5711-1</gtr:outcomeId><gtr:partnerContribution>We generated improved research techniques and animal models to support research. Publications: 17110582, 19233184</gtr:partnerContribution><gtr:piContribution>We generated improved research techniques and animal models to support research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Research Abstracts</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>92417D8D-E96F-4F45-AF71-58A7C78E6751</gtr:id><gtr:impact>Multiple abstarcts at the British, European and Association for the Study of Liver Diseases between 2004-2006

Increased scientific collaborators and access to research material. Transfer of Knowledge</gtr:impact><gtr:outcomeId>976FCBF3A24</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Clinician Scientist Fellowship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>97B1E05D-12CC-4C6E-AD79-9D767A4872C1</gtr:id><gtr:outcomeId>4103E72171C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Liver Trust Research Grant</gtr:description><gtr:fundingOrg>British Liver Trust</gtr:fundingOrg><gtr:id>52E20903-7F57-4F3B-B81B-6A2FBCC7163E</gtr:id><gtr:outcomeId>E53C387D4490</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>00D01A78-5629-487C-B423-2245666E684D</gtr:id><gtr:title>Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>06E37FE1606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D51151D-BEB5-4784-A1A3-2194E536E8A4</gtr:id><gtr:title>Immune regulation and colitis: suppression of acute inflammation allows the development of chronic inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>D8ABB99DEAE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F780F3B1-84D0-4889-9B0A-798B09DEEEDD</gtr:id><gtr:title>Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/856c31f0b7d46b833b854dca3afb28a6"><gtr:id>856c31f0b7d46b833b854dca3afb28a6</gtr:id><gtr:otherNames>Adams DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>0276EF4E09A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71D6E365-7E33-4A24-BBAB-EF9E48E36B94</gtr:id><gtr:title>CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/890266f4d18e3b6fd4ad1b7fb34ba25c"><gtr:id>890266f4d18e3b6fd4ad1b7fb34ba25c</gtr:id><gtr:otherNames>Heydtmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>F70AB9B68AE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E28BFF1-94BD-40AB-9671-83484F34B0A8</gtr:id><gtr:title>CXCR 3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52e78455e73e8f0ac25b59baf9a84b09"><gtr:id>52e78455e73e8f0ac25b59baf9a84b09</gtr:id><gtr:otherNames>Curbishley SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>638D9242027</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95960554-261C-4E56-B8C7-E7BAE94F2289</gtr:id><gtr:title>Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Clinical medicine (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1470-2118</gtr:issn><gtr:outcomeId>45FC86B2BEC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0167FAA-5A86-4A8F-A90C-FFD7A6E22C63</gtr:id><gtr:title>Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f991f5733bfdcb106e59df3e5664d189"><gtr:id>f991f5733bfdcb106e59df3e5664d189</gtr:id><gtr:otherNames>Eksteen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>AC14786230F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6524</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>